Probiotics

Scientific Documentation

• Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr. 2000 Apr;54(4):288-97 (a).
• Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A. The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur J Clin Nutr. 2000 Nov;54(11):856-60 (b).
• Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G.l. Atopy in children of families with anthroposophic lifestyle. Lancet 1999; 353: 1485-1489..
• Arvola T, Laiho K, Torkkeli S, Mykkänen H, Salminen S, Maunula L, Isolauri E. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999 104(5):e64.
• Asahara T, Nomoto K, Watanuki M, Yokokura T. Related Articles Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother. 2001;45(6):1751-60 (Abstract)
• Bengmark S. Bacteria for optimal health. Nutrition 2000; 16: 611-615.
• Björksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy. 1999;29(3):342-6.
• Buddington KK, Donahoo JB, Buddington RK. Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers. J Nutr. 2002;132(3):472-7.
• Duggan C, Gannon J, Walker WA. Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr 2002;75:789-808
• Flamm G, Glinsmann W, Kritchevsky D, Prosky L, Roberfroid M. Inulin and oligofructose as dietary fiber: a review of the evidence. Crit Rev Food Sci Nutr. 2001;41(5):353-62. Review.
• Fukuda M, Kanauchi O, Araki Y, Andoh A, Mitsuyama K, Takagi K, Toyonaga A, Sata M, Fujiyama Y, Fukuoka M, Matsumoto Y, Bamba T. Prebiotic treatment of experimental colitis with germinated barley foodstuff: A comparison with probiotic or antibiotic treatment. Int J Mol Med. 2002;9(1):65-70.
• He F, Ouwehan AC, Hashimoto H, Isolauri E, Benno Y, Salminen S. Adhesion of Bifidobacterium spp. to human intestinal mucus. Microbiol Immunol. 2001;45(3):259-62.
• He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. Related Articles Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol. 2001;30(1):43-7.
• Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy. 2002;57(3):243-6.
• Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17(4):259-68. Review.
• Hughes R, Rowland IR. Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis. 2001;22(1):43-7.
• Isolauri E. The use of probiotics in paediatrics. Hosp Med. 2000;61(1):6-7.
• Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S.. Probiotics: effects on immunity. Am J Clin Nutr 2001; 73: 444S-450S.
• Isolauri E. Probiotics in human disease. Am J Clin Nutr. 2001;73(6):1142S-1146S. Review.
• Isolauri E. Probiotics in the prevention and treatment of allergic disease. Pediatr Allergy Immunol. 2001;12(S14):56-9.
• Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(2 Suppl):444S-450S. Review.
• Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30(11):1604-10.
• Isolauri E, Kirjavainen PV, Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut. 2002 May;50 Suppl 3:III54-III59.
• Jackson KG, Taylor GR, Willams CM. The effect of daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr 1999;82:23-30
• Juntunen M, Kirjavainen PV, Ouwehand AC, Salminen SJ, Isolauri E. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol. 2001;8(2):293-6.
• Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001;107(1):129-34.
• Kalliomäki M, Laippala P, Korvenranta H, Kero P, Isolauri E. Extent of fussing and colic type crying preceding atopic disease. Arch Dis Child. 2001 Apr;84(4):349-50.
• Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357(9262):1076-9.
• Kamm MA. New therapeutic possibilities in inflammatory bowel disease. Eur J Surg Suppl. 2001;(586):30-3.
• Kankaanpää PE, Salminen SJ, Isolauri E, Lee YK. The influence of polyunsaturated fatty acids on probiotic growth and adhesion. FEMS Microbiol Lett. 2001;194(2):149-53.
• Kilpi T, Kero J, Jokinen J, Syrjänen R, Takala AK, Hovi T, Isolauri E. Related Articles Common respiratory infections early in life may reduce the risk of atopic dermatitis. Clin Infect Dis. 2002;34(5):620-6.
• Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR, Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol. 2001;32(1):1-7.(Abstract)
• Kirjavainen PV, Gibson GR. Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann Med. 1999;31(4):288-92. Review.
• Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc. 2001;101(2):229-38; quiz 239-41. Review. (Abstract).
• Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99(2):179-85.
• Marteau P. Inflammatory bowel disease. Endoscopy. 2000;32(2):131-7. Review.
• Niggemann B, Binder C, Dupont C, Hadji S, Arvola T, Isolauri E. Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis. Pediatr Allergy Immunol. 2001;12(2):78-82.
• Niebauer J et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353: 1838-42.
• Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol. 2000;108(1):144-5.
• Pessi T, Sutas Y, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy. 2000;30(12):1804-8.
• Rautava S, Kalliomäki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol. 2002;109(1):119-21.(Abstract) .
• Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001; 73: 437S-443S.(Abstract)
• Reid G, Bruce AW. Could probiotics be an option for treating and preventing urogenital infections? Medscape Womens Health. 2001;6(5):9 (Abstract)
• Roberfroid MB. Prebiotics: preferential substrates for specific germs? Am J Clin Nutr. 2001;73(2 Suppl):406S-409S. Review.
• Roberfroid M, Slavin J. Nondigestible oligosaccharides. Crit Rev Food Sci Nutr. 2000;40(6):461-80. Review.
• Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr. 2000;71(6 Suppl):1682S-7S; discussion 1688S-90S. Review.
• Roberfroid MB. Concepts and strategy of functional food science: the European perspective. Am J Clin Nutr. 2000 Jun;71(6 Suppl):1660S-4S; discussion 1674S-5S. Review.
• Saavedra JM. Clinical applications of probiotic agents. Am J Clin Nutr. 2001;73(6):1147S-1151S. Review.
• Sands BE. Biological therapies for ulcerative colitis. Acta Gastroenterol Belg. 2001;64(2):205-9. Review.
• Schrezenmeier J et al. Probiotics, prebiotics, and synbiotics - approaching a definition. Am J Clin Nutr. 2001; 73: 361S-364S.
• Taper HS, Roberfroid M. Influence of inulin and oligofructose on breast cancer and tumor growth. J Nutr. 1999;129(7 Suppl):1488S-91S. Review.
• Taper HS, Roberfroid MB. Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin. Nutr Cancer. 2000;38(1):1-5.
• Tuomola E et al. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr. 2001;73: 393S-398S.
• Uehara M, Ohta A, Sakai K, Suzuki K, Watanabe S, Adlercreutz H. Dietary fructooligosaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinary excretion and kinetics in blood of rats. J Nutr. 2001;131(3):787-95.
• Ulisse S, Gionchetti P, D'Alo S, Russo FP, Pesce I, Ricci G, Rizzello F, Helwig U, Cifone MG, Campieri M, De Simone C. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol. 2001;96(9):2691-9 (Abstract) .
• Wollowski I, Rechkemmer G, Pool-Zobelet BL et al. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 2001; 73: 451S-455S. (Full article)
• Wollowski I, Ji ST, Bakalinsky AT, Neudecker C, Pool-Zobel BL. Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J Nutr. 1999;129(1):77-82.Abstract